Biodel Inc.

(NASDAQ:BIOD)

2.62

+0.18 (7.38%)

Dec 02 - Close

Open
2.60
High
2.70
Low
2.47
Vol.
163.17K
Mkt Cap
57.75M
52Wk High
25.69
52Wk Low
1.62
Avg. Vol.
205.10K
P/E (Trailing)
-1.40
Beta
0.70
Short %
7.30%
Div. Yield
—

After-Hours 2.64 +0.02 (0.76%) Tue, 2 Dec 2008 7:40 PM

Company Profile

Biodel Inc.

100 Saw Mill Road

Danbury, CT 06810

United States - Map

Phone: (203) 796-5000

Fax: (203) 796-5001

Website: www.biodel.com

CEO: Dr. Solomon S. Steiner

Employees: 30

Sector: Healthcare

Industry Group: Drugs

Industry: Drug Manufacturers - Other

Dvlp & commlz treatments for endocine disorders

A biopharmaceutical company focused on the development and commercialization of innovative treatments for endocrine disorders such as diabetes and osteoporosis.

Recent news for BIOD

Recent opinions on BIOD

No recent Opinions for BIOD

No members own BIOD

Member sentiment: Neutral